Upgrade to SI Premium - Free Trial

Raymond James Downgrades Amphastar Pharmaceuticals (AMPH) to Market Perform

November 9, 2017 4:40 AM
Raymond James downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles